| |
• Effectiveness of Rely+On Virkon against Mpox pathogens scientifically proven;
• Disinfection is the key to preventing transmission.
In view of the increasing Mpox infections in Central and East Africa, the World Health Organization (WHO) has declared an international health emergency.
The disinfectant Rely+On Virkon from specialty chemicals company LANXESS has been proven to be effective against the Mpox virus, formerly known as the “monkeypox virus”. This is confirmed by independent tests that confirm the product's effectiveness against the virus.
“Especially in times of rising infection rates, the choice of an effective disinfectant that has been proven to kill the target pathogen is crucial,” says Roy van Wel, Head of the market segment Hygiene and Care at LANXESS.
Rely+On Virkon is used for the disinfection of hard surfaces in hospitals, healthcare facilities, airports, public transportation terminals, clinics, shopping malls and many other public places.
Rely+On Virkon has proven to be effective against the pathogen and supports prevention in risk areas. It provides effective inactivation of the virus on hard surfaces, helping to contain the spread.
About LANXESS
LANXESS (lanxess.com) is a leading specialty chemicals company with sales of EUR 6.7 billion in 2023. The company currently has about 12,800 employees in 32 countries. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives and consumer protection products. LANXESS is listed in the leading sustainability indices of the Dow Jones Sustainability Index (DJSI World and Europe).
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.
|
mark.maetschke[.]lanxess.com 
